Tirzepatide Side Effects in Women
What side effects do women get on tirzepatide?
Reviewed by Taylor Anderson, RN
Aesthetic Registered Nurse
Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.
Updated November 15, 2026
Quick answer
The most common tirzepatide side effects in women are nausea, diarrhea, constipation and vomiting, plus hair shedding, which shows up far more often in women than in men. Tirzepatide's stomach side effects mostly show up while the dose is being raised, are usually mild to moderate, and ease over time.
Want the weight off? See which GLP-1 option fits your budget.
See My PlanIn this guide
Key takeaways
- Nausea is the most common tirzepatide side effect, it is more likely at higher doses, and few people get a severe stomach side effect.
- Hair shedding on tirzepatide happens far more often in women than in men, and nobody stopped taking it because of shedding.
- Most of the weight you lose on tirzepatide is fat, and the share that comes from muscle is about the same as when you lose weight with diet and exercise alone.
- Tirzepatide's stomach side effects mostly hit while your dose is going up and ease over time, and nausea is common on the starting dose.
- You do not have to feel sick for tirzepatide to work, because people with and without stomach side effects lose about the same amount of weight.
The most common tirzepatide side effects in women are nausea, diarrhea, constipation and vomiting, plus hair shedding, which the Zepbound label reports in 7.1% of women versus 0.5% of men. The stomach side effects mostly show up while your dose is being raised, are mostly mild to moderate, and ease over time, according to the label and the SURMOUNT-1 trial. Your clinical team can prescribe tirzepatide if it fits your goal, so take the quiz to start a plan.
How common is each tirzepatide side effect?
Nausea is the most common, and it is more likely at the 10 mg and 15 mg doses than at 5 mg. Most people on tirzepatide had some stomach side effect. Few had a severe one.
| Side effect | Tirzepatide 5 mg | 10 mg | 15 mg | Placebo | Source |
|---|---|---|---|---|---|
| Nausea | 24.6% | 33.3% | 31.0% | 9.5% | SURMOUNT-1 |
| Diarrhea | 18.7% | 21.2% | 23.0% | 7.3% | SURMOUNT-1 |
| Constipation | 16.8% | 17.1% | 11.7% | 5.8% | SURMOUNT-1 |
| Vomiting | 8.3% | 10.7% | 12.2% | 1.7% | SURMOUNT-1 |
| Any stomach side effect | 56% | 56% | 56% | 30% | Zepbound label |
| Severe stomach side effect | 1.7% | 2.5% | 3.1% | 1% | Zepbound label |
| Stopped because of stomach side effects | 1.9% | 3.3% | 4.3% | 0.5% | Zepbound label |
| Hair loss | 7.1% of women, 0.5% of men | All doses combined | All doses combined | 1.3% of women, 0% of men | Zepbound label |
SURMOUNT-1 treated 2,539 adults with obesity or overweight and no diabetes for 72 weeks, including a 20-week period of dose increases. The label rows pool its two main weight trials.
The label lists other side effects that showed up in at least 5% of people: belly pain, indigestion, injection site reactions, feeling tired, allergic reactions, burping and heartburn.
Women made up a bigger share of the people with stomach side effects. In SURMOUNT-1, 76.2% of participants who reported one were women, compared with 62.8% of those who reported none.
Reports sent to FDA after the drug went on sale show a different pattern by sex. In an analysis of those adverse event reports, women were more likely than men to report itching at the injection site, and men were more likely to report diarrhea.
Will tirzepatide make my hair fall out or cost me muscle?
Hair shedding is the side effect that leans hardest toward women. The Zepbound label reports it in 7.1% of women vs 0.5% of men, and no one taking Zepbound in those trials stopped because of it. For what shedding looks like and what helps, read our guide to hair loss after rapid weight loss.
Most of the weight you lose is fat. In a scanned subgroup of 160 people from SURMOUNT-1, 73% of them women, followed for 72 weeks, most of the weight lost on tirzepatide was fat. The share lost as lean mass was about the same as in the placebo group. To hold on to muscle while the scale drops, see how to keep muscle on a GLP-1.
How long do tirzepatide side effects last?
Most nausea, vomiting and diarrhea happens while your dose is being raised, then eases over time, according to the Zepbound label. In FDA adverse event reports, nausea and injection site pain came up more often at the 2.5 mg starting dose than at 5 mg or 7.5 mg.
You do not have to feel sick for tirzepatide to work. Across the SURMOUNT trials, people with and without nausea, vomiting or diarrhea lost similar amounts of weight. On 15 mg in SURMOUNT-1, people with those side effects lost 22.8% of their body weight and people without them lost 22.2%. Fewer than one in three participants used medicine for stomach symptoms.
If side effects make you pause, the price can change. LillyDirect lists Zepbound vials at $449 a month self-pay for the 7.5, 10, 12.5 and 15 mg doses with its Journey Program, but only if you refill within 45 days. If you miss that window, the price goes to $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg (checked November 2026).
If you wonder whether another GLP-1 is gentler on your stomach, read which GLP-1 has the fewest side effects. For how the two biggest options compare on results, see tirzepatide vs semaglutide for weight loss. Every weight treatment we offer is on the weight hub.
What women share
We collected 397 GLP-1 threads from October 2025 to October 2026, and 152 of them mentioned tirzepatide. We read 6 tirzepatide threads in full, posted September 20 to October 1, 2026, in r/Zepbound and r/tirzepatidecompound. 2 of 6 reported their own side effects, 2 of 6 talked about keeping protein high while losing weight, and 1 of 6 stopped because of side effects.
The two who described their own side effects sat at opposite ends. One person stayed on the starting dose, lost 23 lbs and stopped after a little over two months: "I started at the lowest dose (2.5 mg), and never increased, due to side effects." The same post said: "Two trips to the ER in the last 3 weeks." Their advice: "Listen to your body while it whispers, before it starts to yell."
The other reached their goal after losing 77.4 lbs over 16 months on Zepbound, with few problems: "Very few side effects and am very conscious of getting enough protein and drinking water."
When should I call my clinical team about side effects?
Call right away for nausea, vomiting or diarrhea that will not go away, or for any sign of a gallbladder or thyroid problem. Milder stomach upset after a dose increase can wait for your next check-in. A GLP-1 side-effect tracker app lets you show your clinical team which dose each symptom came after.
| What you notice | What it can mean | What to do |
|---|---|---|
| Mild nausea or fullness in the weeks after a dose increase | The most common side effect, and it usually eases | Bring it up at your next check-in |
| Nausea, vomiting or diarrhea that will not go away | Losing fluids can cause dehydration, which can lead to kidney problems | Call your clinical team right away and keep drinking fluids |
| Stomach problems that are severe or will not go away | A side effect that needs a closer look | Contact your clinical team |
| You think you may have a gallbladder problem | A possible gallbladder issue | Contact your clinical team |
| A lump in your neck, hoarseness that lasts, trouble swallowing or shortness of breath | Possible thyroid tumor symptoms. The label carries a boxed warning about thyroid tumors seen in rats | Report it to your clinical team |
| You become pregnant | The label says it may cause harm to the baby | Stop and tell your clinical team |
| Surgery or a procedure coming up | It may raise the chance of food getting into your lungs | Tell every provider you take it |
| Hair shedding | Common in women, and no one in the trials stopped for it | Raise it with your clinical team |
Tirzepatide is not for women with a personal or family history of medullary thyroid cancer or MEN 2 (multiple endocrine neoplasia type 2, an inherited condition that causes tumors in hormone glands), and the Zepbound label does not recommend it with severe gastroparesis, a condition where the stomach empties very slowly.
You want the weight off without months of feeling queasy. Take the quiz to see if tirzepatide fits your goal. Your clinical team reviews your answers and tells you what to watch for as your dose goes up.
Ready to make a move?
Answer three questions to see the treatment options that fit your goals.
See My PlanFAQ
Do tirzepatide side effects mean it's working?
No, you do not have to feel sick for tirzepatide to work. Across the SURMOUNT trials, people with and without nausea, vomiting or diarrhea lost similar amounts of weight. On the 15 mg dose in SURMOUNT-1, people with those side effects lost 22.8% of their body weight and people without them lost 22.2%.
Can you get side effects on 2.5 mg tirzepatide?
Yes, you can get side effects on the 2.5 mg starting dose. In reports sent to FDA, nausea and injection site pain came up more often at 2.5 mg than at 5 mg or 7.5 mg. The Zepbound label says most nausea, vomiting and diarrhea happens while the dose is being raised and then eases over time.
Does Mounjaro have the same side effects as Zepbound?
Mounjaro and Zepbound both contain tirzepatide, and nausea, diarrhea and vomiting are its most common side effects. In reports sent to FDA after the drugs went on sale, Mounjaro, which is mostly used for diabetes, was linked more often to stomach problems such as slow stomach emptying. Zepbound, which is used for weight loss, was linked more often to injection site reactions.
Can I take tirzepatide if thyroid cancer runs in my family?
Not if you or a family member has had medullary thyroid cancer, or if you have MEN 2, an inherited condition that causes tumors in hormone glands. The Zepbound label carries a boxed warning because tirzepatide caused thyroid tumors in rats, and it is not known whether it does this in people. Your clinical team reviews your health history in the quiz and decides whether tirzepatide fits.
Keep reading
Sources (5)
- Tirzepatide Once Weekly for the Treatment of Obesity · nejm.org · captured November 14, 2026
- Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials · pmc.ncbi.nlm.nih.gov · captured November 14, 2026
- Adverse events associated with tirzepatide: a focus on subgroup-specific differences | BMC Pharmacology and Toxicology | Springer Nature Link · link.springer.com · captured November 14, 2026
- Body composition changes during weight reduction with tirzepatide in the <fc>SURMOUNT</fc>‐1 study of adults with obesity or overweight - Look - 2025 - Diabetes, Obesity and Metabolism - Wiley Online Library · dom-pubs.onlinelibrary.wiley.com · captured November 14, 2026
- ZEPBOUND (tirzepatide) injection, for subcutaneous use · accessdata.fda.gov · captured November 14, 2026
